Agios Pharmaceuticals, Inc. (AGIO)
USD 30.1
(-2.71%)
USD 30.1
(-2.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 17.31 Million USD | 38.15% |
| 2022 | 12.53 Million USD | 166.76% |
| 2021 | -18.77 Million USD | -109.37% |
| 2020 | 200.39 Million USD | 71.87% |
| 2019 | 116.59 Million USD | 25.38% |
| 2018 | 92.99 Million USD | 137.25% |
| 2017 | -249.67 Million USD | -66.15% |
| 2016 | -150.27 Million USD | -81.69% |
| 2015 | -82.7 Million USD | -136.22% |
| 2014 | -35.01 Million USD | -20.93% |
| 2013 | -28.95 Million USD | -81.75% |
| 2012 | -15.93 Million USD | -172.95% |
| 2011 | 21.83 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 5.52 Million USD | -11.06% |
| 2024 Q3 | 8.18 Million USD | 48.02% |
| 2024 Q1 | 6.21 Million USD | 21.51% |
| 2023 Q3 | 6.76 Million USD | 20.74% |
| 2023 Q1 | 5.05 Million USD | 29.72% |
| 2023 FY | 17.31 Million USD | 38.15% |
| 2023 Q2 | 5.6 Million USD | 10.86% |
| 2023 Q4 | 5.11 Million USD | -24.42% |
| 2022 Q4 | 3.89 Million USD | 29.94% |
| 2022 Q3 | 2.99 Million USD | -41.73% |
| 2022 Q2 | 5.14 Million USD | 944.02% |
| 2022 Q1 | 493 Thousand USD | 110.69% |
| 2022 FY | 12.53 Million USD | 166.76% |
| 2021 Q4 | -4.61 Million USD | -0.7% |
| 2021 Q1 | 40.7 Million USD | -5.53% |
| 2021 FY | -18.77 Million USD | -109.37% |
| 2021 Q2 | 36.67 Million USD | -9.9% |
| 2021 Q3 | -4.57 Million USD | -112.48% |
| 2020 Q4 | 43.08 Million USD | 26.47% |
| 2020 FY | 200.39 Million USD | 71.87% |
| 2020 Q1 | 86.56 Million USD | 146.25% |
| 2020 Q3 | 34.06 Million USD | -7.1% |
| 2020 Q2 | 36.67 Million USD | -57.64% |
| 2019 Q4 | 35.15 Million USD | 37.15% |
| 2019 Q2 | 25.91 Million USD | -13.3% |
| 2019 Q1 | 29.89 Million USD | 1.99% |
| 2019 FY | 116.59 Million USD | 25.38% |
| 2019 Q3 | 25.63 Million USD | -1.11% |
| 2018 Q2 | -46.31 Million USD | 33.32% |
| 2018 Q1 | -69.46 Million USD | -3.03% |
| 2018 Q4 | 29.31 Million USD | 102.1% |
| 2018 FY | 92.99 Million USD | 137.25% |
| 2018 Q3 | 14.5 Million USD | 131.31% |
| 2017 Q3 | -61.55 Million USD | 10.09% |
| 2017 Q4 | -67.41 Million USD | -9.52% |
| 2017 FY | -249.67 Million USD | -66.15% |
| 2017 Q1 | -52.22 Million USD | -24.25% |
| 2017 Q2 | -68.47 Million USD | -31.11% |
| 2016 Q1 | -12.75 Million USD | 58.47% |
| 2016 FY | -150.27 Million USD | -81.69% |
| 2016 Q3 | -51.65 Million USD | -17.87% |
| 2016 Q4 | -42.03 Million USD | 18.64% |
| 2016 Q2 | -43.82 Million USD | -243.54% |
| 2015 Q1 | 1.75 Million USD | 108.7% |
| 2015 FY | -82.7 Million USD | -136.22% |
| 2015 Q4 | -30.71 Million USD | -0.55% |
| 2015 Q3 | -30.54 Million USD | -31.65% |
| 2015 Q2 | -23.2 Million USD | -1419.16% |
| 2014 Q2 | -14.16 Million USD | -57.46% |
| 2014 Q1 | -8.99 Million USD | -5.4% |
| 2014 FY | -35.01 Million USD | -20.93% |
| 2014 Q4 | -20.22 Million USD | -341.53% |
| 2014 Q3 | 8.37 Million USD | 159.12% |
| 2013 Q3 | -8.53 Million USD | -27.58% |
| 2013 Q2 | -6.69 Million USD | -28.8% |
| 2013 Q1 | -5.19 Million USD | -5.08% |
| 2013 FY | -28.95 Million USD | -81.75% |
| 2013 Q4 | -8.53 Million USD | 0.0% |
| 2012 FY | -15.93 Million USD | -172.95% |
| 2012 Q2 | 6.28 Million USD | 0.32% |
| 2012 Q3 | -3.53 Million USD | -156.14% |
| 2012 Q4 | -4.94 Million USD | -40.03% |
| 2012 Q1 | 6.26 Million USD | 0.0% |
| 2011 FY | 21.83 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 141.385% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 81.716% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 98.859% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 34232.834% |
| Apollomics, Inc. | 127 Thousand USD | -13537.008% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 16488.928% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 75400.0% |
| Bicycle Therapeutics plc | -129.52 Million USD | 113.372% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -2059.476% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -14332.5% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 13.63% |
| Chimerix, Inc. | 324 Thousand USD | -5245.37% |
| CRISPR Therapeutics AG | 240.95 Million USD | 92.812% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 65.226% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 58.153% |
| Fortress Biotech, Inc. | 57.85 Million USD | 70.064% |
| Fortress Biotech, Inc. | 57.85 Million USD | 70.064% |
| Gritstone bio, Inc. | -6.26 Million USD | 376.661% |
| Allakos Inc. | -6.14 Million USD | 382.022% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 1909.718% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -17.068% |
| Cytokinetics, Incorporated | -322.59 Million USD | 105.369% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 9996.571% |
| Innoviva, Inc. | 261.06 Million USD | 93.366% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 151914.516% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 587.722% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 172411.213% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 2065.834% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 4440.602% |
| ImmuCell Corporation | 4.39 Million USD | -293.946% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 116.32% |
| Incyte Corporation | 3.44 Billion USD | 99.497% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 748.281% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -8794.858% |
| Mustang Bio, Inc. | -2.22 Million USD | 878.382% |
| MiMedx Group, Inc. | 266.84 Million USD | 93.51% |
| MEI Pharma, Inc. | 49.32 Million USD | 64.889% |
| MacroGenics, Inc. | 50.52 Million USD | 65.723% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -133.221% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 343.735% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 40.392% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 87.647% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 56000.2% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 17954.639% |
| NextCure, Inc. | -3.68 Million USD | 570.114% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -572.844% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 9.053% |
| Onconetix, Inc. | -1.12 Million USD | 1636.51% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 159.787% |
| Opthea Limited | 21.72 Thousand USD | -79637.569% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 1537.405% |
| Psyence Biomedical Ltd. | -240.00 USD | 7216350.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 30311.422% |
| Precigen, Inc. | 106 Thousand USD | -16238.679% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -1616.452% |
| Prime Medicine, Inc. | -147.9 Million USD | 111.71% |
| PureTech Health plc | -1.6 Million USD | 1180.412% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 343.998% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.847% |
| Replimune Group, Inc. | -2.65 Million USD | 752.316% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 69240.485% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 84.223% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 3451.55% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 104.333% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 56.703% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 138.211% |
| Solid Biosciences Inc. | -76.56 Million USD | 122.621% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 144425.0% |
| SciSparc Ltd. | 2.19 Million USD | -688.661% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 164.88% |
| TG Therapeutics, Inc. | 219.1 Million USD | 92.096% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -472.151% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 1101.677% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 87.055% |
| UroGen Pharma Ltd. | 73.35 Million USD | 76.389% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -295.592% |
| XOMA Corporation | 3.86 Million USD | -348.563% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 1346.868% |
| AbCellera Biologics Inc. | 38.02 Million USD | 54.454% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 346480.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 119.368% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 155.567% |
| Precision BioSciences, Inc. | 40.47 Million USD | 57.207% |
| Dyadic International, Inc. | 922.95 Thousand USD | -1776.469% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 11881.633% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 17.767% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -3984.67% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 299.367% |
| IGM Biosciences, Inc. | -211.66 Million USD | 108.182% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 967.685% |
| Acelyrin, Inc. | -115 Thousand USD | 15160.0% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -611.253% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 85.538% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 229.654% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 88.811% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 117.633% |
| Senti Biosciences, Inc. | -2.68 Million USD | 745.509% |
| Mesoblast Limited | -9.81 Million USD | 276.454% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 115.675% |
| ChromaDex Corporation | 50.78 Million USD | 65.894% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 85.624% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -146.464% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 87.197% |
| Novavax, Inc. | 639.93 Million USD | 97.294% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 117.643% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 139.848% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -13222.308% |
| Celcuity Inc. | -142.77 Thousand USD | 12230.53% |
| ContextLogic Inc. | 59 Million USD | 70.646% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -3262.913% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -4.476% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 99.49% |
| Amarin Corporation plc | 165.54 Million USD | 89.538% |
| AnaptysBio, Inc. | 14.78 Million USD | -17.171% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 3154.497% |
| Aptorum Group Limited | -1.11 Million USD | 1653.708% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 29.169% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 92.806% |
| Ardelyx, Inc. | 106.66 Million USD | 83.763% |
| Celularity Inc. | 6.75 Million USD | -156.388% |
| Omeros Corporation | -69.77 Million USD | 124.82% |
| Humacyte, Inc. | -76.55 Million USD | 122.624% |
| Immunocore Holdings plc | 248.39 Million USD | 93.028% |
| IO Biotech, Inc. | -756 Thousand USD | 2390.873% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 1314.516% |
| Summit Therapeutics Inc. | -2.05 Million USD | 944.829% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 460.963% |
| Pulmatrix, Inc. | -8.22 Million USD | 310.693% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 104.343% |
| Evogene Ltd. | 1.39 Million USD | -1137.956% |
| CorMedix Inc. | -205.56 Thousand USD | 8525.195% |
| BioLineRx Ltd. | 1.1 Million USD | -1463.087% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -3391.734% |
| Sagimet Biosciences Inc. | 2 Million USD | -765.95% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 98.015% |
| scPharmaceuticals Inc. | 9.78 Million USD | -77.05% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 125.101% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 96.361% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 151914.516% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 59820.69% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 9263.492% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -327.524% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 3398.857% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 39293.899% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 265.812% |
| Daré Bioscience, Inc. | 2.76 Million USD | -525.343% |
| bluebird bio, Inc. | -4.03 Million USD | 529.752% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 99.091% |
| DBV Technologies S.A. | 15.72 Million USD | -10.116% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 109.547% |
| Galecto, Inc. | -830 Thousand USD | 2186.627% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 3133.1% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 144.021% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -2743.842% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 12185.75% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 68.291% |
| ADMA Biologics, Inc. | 88.21 Million USD | 80.368% |
| Clene Inc. | 533 Thousand USD | -3149.343% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -771.177% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 3749.601% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 166628.846% |
| Soligenix, Inc. | 97.31 Thousand USD | -17697.577% |
| Century Therapeutics, Inc. | -10.8 Million USD | 260.228% |
| Kura Oncology, Inc. | -849 Thousand USD | 2139.929% |
| Surrozen, Inc. | -27.23 Million USD | 163.603% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 125.809% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 82.513% |
| Autolus Therapeutics plc | -4.86 Million USD | 455.845% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 10408.929% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 122.319% |
| GRI Bio, Inc. | 10.84 Million USD | -59.755% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -581.854% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 136.976% |
| INmune Bio, Inc. | 155 Thousand USD | -11073.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 72.039% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 1249.778% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 2770.814% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 228884.676% |
| Jaguar Health, Inc. | 7.72 Million USD | -124.223% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 59261.713% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -4208.209% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -120.036% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 5633.227% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 81.665% |
| Verastem, Inc. | -62 Thousand USD | 28033.871% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 6735.632% |
| Histogen Inc. | 3.76 Million USD | -359.512% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -2905.837% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 97.456% |
| Surrozen, Inc. | -27.23 Million USD | 163.603% |
| Organovo Holdings, Inc. | -5.38 Million USD | 421.377% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 874796.97% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -185.489% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 25898.811% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -11778.601% |
| Kronos Bio, Inc. | 1.37 Million USD | -1162.318% |
| Turnstone Biologics Corp. | 16.5 Million USD | -4.925% |
| Synaptogenix, Inc. | -6347.00 USD | 272969.072% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 34058.824% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 40.544% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 89.267% |
| Exelixis, Inc. | 1.75 Billion USD | 99.015% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 115.441% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 94.877% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1663.087% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 14716.3% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -136.663% |
| Insmed Incorporated | 239.63 Million USD | 92.773% |
| MediWound Ltd. | 3.57 Million USD | -384.041% |
| OmniAb, Inc. | 14.66 Million USD | -18.081% |
| Alector, Inc. | -95.05 Million USD | 118.22% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 86.213% |
| Zai Lab Limited | 170.9 Million USD | 89.866% |
| AlloVir, Inc. | -398 Thousand USD | 4451.508% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 78.848% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 1778.198% |
| Aura Biosciences, Inc. | -1.29 Million USD | 1437.375% |
| Immunic, Inc. | -111 Thousand USD | 15702.703% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -9.241% |
| Veracyte, Inc. | 248.14 Million USD | 93.021% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.248% |
| FibroGen, Inc. | 128.9 Million USD | 86.564% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 94.479% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 3070844.681% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 248.446% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -4352.185% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 95.126% |
| Fortrea Holdings Inc. | 424 Million USD | 95.915% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 120.099% |
| XBiotech Inc. | -1.74 Million USD | 1093.062% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 1663.087% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 2708.283% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 137.268% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 122.929% |
| Agenus Inc. | 139.61 Million USD | 87.595% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 76.406% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -3.071% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 95.548% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 134.884% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 94.7% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 252.943% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 117.864% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -320622.222% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 26016.172% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 10005.458% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 4730.749% |
| Ainos, Inc. | -253.73 Thousand USD | 6925.679% |
| Pluri Inc. | 322 Thousand USD | -5278.571% |
| Prothena Corporation plc | -129.2 Million USD | 113.405% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 65.653% |
| Rallybio Corporation | -150 Thousand USD | 11646.0% |
| Kodiak Sciences Inc. | -25.94 Million USD | 166.748% |
| Cue Biopharma, Inc. | -32.6 Million USD | 153.114% |
| MeiraGTx Holdings plc | 287 Thousand USD | -5934.495% |
| Annexon, Inc. | -3.26 Million USD | 630.119% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 141.496% |
| Moderna, Inc. | 2.15 Billion USD | 99.196% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 214.174% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 72.237% |
| Blueprint Medicines Corporation | 236.58 Million USD | 92.68% |
| Immix Biopharma, Inc. | -5468.00 USD | 316833.723% |
| CalciMedica, Inc. | -58 Thousand USD | 29960.345% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 378.351% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 708.966% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 83.363% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 156.112% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 1580.256% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -523.977% |
| Nutriband Inc. | 862.1 Thousand USD | -1908.92% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 5178.886% |
| Vor Biopharma Inc. | -3.49 Million USD | 595.962% |
| Roivant Sciences Ltd. | 109.23 Million USD | 84.145% |
| Alkermes plc | 1.37 Billion USD | 98.74% |
| ProKidney Corp. | -3.16 Million USD | 646.513% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 139.44% |
| Arcellx, Inc. | 108.27 Million USD | 84.005% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -152.574% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 122.014% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 52581.818% |
| Atai Life Sciences N.V. | -5000.00 USD | 346480.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 14312.327% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 18140.625% |
| MediciNova, Inc. | 979.7 Thousand USD | -1667.777% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 120.54% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 18416.324% |
| GeoVax Labs, Inc. | -20.72 Million USD | 183.583% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 92.918% |
| Biomea Fusion, Inc. | -4.2 Million USD | 512.259% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 5686.774% |
| Geron Corporation | -123.5 Million USD | 114.023% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 346480.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 122.677% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 803.738% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 91.897% |
| Royalty Pharma plc | 1.79 Billion USD | 99.035% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 1940.489% |
| Imunon, Inc. | -720 Thousand USD | 2505.4% |
| BioAtla, Inc. | -103.73 Million USD | 116.696% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 107.132% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 5668.81% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 115.545% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 1924.639% |
| 89bio, Inc. | -273 Thousand USD | 6443.956% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 124.711% |
| aTyr Pharma, Inc. | -2.38 Million USD | 825.251% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -38.997% |
| Viridian Therapeutics, Inc. | -1 Million USD | 1818.155% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -133222976.923% |
| Akari Therapeutics, Plc | -4000.00 USD | 433075.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 97.281% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -1447.721% |
| Liquidia Corporation | 14.6 Million USD | -18.623% |
| Entera Bio Ltd. | -56 Thousand USD | 31026.786% |
| GH Research PLC | -315 Thousand USD | 5598.095% |
| Vericel Corporation | 135.57 Million USD | 87.226% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 131.172% |
| Xencor, Inc. | -85.26 Million USD | 120.313% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 7937.467% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 2770.814% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 1829.762% |
| Vaxcyte, Inc. | -75 Million USD | 123.092% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 110.339% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 90.262% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -8794.858% |
| Portage Biotech Inc. | -54 Thousand USD | 32172.222% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 18416.324% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 4693.899% |
| OncoCyte Corporation | 413 Thousand USD | -4093.462% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 385394.772% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 7801451.351% |
| Purple Biotech Ltd. | -196 Thousand USD | 8936.224% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 4645.669% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 178.769% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 74.578% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -93.12% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 13737.008% |
| United Therapeutics Corporation | 2.07 Billion USD | 99.163% |
| HilleVax, Inc. | -2.15 Million USD | 903.293% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -26036.364% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 539.34% |
| Pharming Group N.V. | 220.1 Million USD | 92.131% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 115529.219% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 2692.665% |
| Pyxis Oncology, Inc. | -2 Million USD | 965.95% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 230830.493% |
| Savara Inc. | -44.26 Million USD | 139.128% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 21220.732% |
| Curis, Inc. | 9.81 Million USD | -76.526% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 13978.738% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 7696.053% |
| BeiGene, Ltd. | 2.07 Billion USD | 99.167% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 69.449% |
| Erasca, Inc. | -3.73 Million USD | 564.068% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 61475.718% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 61475.718% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 1992.787% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -116.325% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 3331.157% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 115.585% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 582.692% |
| Adicet Bio, Inc. | -6.09 Million USD | 384.011% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 95.216% |
| Aditxt, Inc. | -111.66 Thousand USD | 15610.478% |
| Adagene Inc. | 18.11 Million USD | 4.376% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -3448.975% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 89.027% |
| Compugen Ltd. | 31.45 Million USD | 44.94% |
| Generation Bio Co. | -73.91 Million USD | 123.432% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 4063.158% |
| Invivyd, Inc. | -2.02 Million USD | 953.994% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 105.757% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 16843.363% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 82.028% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 82.379% |
| Instil Bio, Inc. | -4.75 Million USD | 464.151% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 28.164% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -1426.468% |
| GeoVax Labs, Inc. | -20.72 Million USD | 183.583% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 9012.802% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 2171.651% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 79.238% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -23588.314% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 67.422% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 110.0% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 5006.232% |
| Cingulate Inc. | -582.91 Thousand USD | 3071.087% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 55967.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 187.918% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 1852.935% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 30839.058% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 132.272% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 6031.164% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 3386.338% |
| ImmunityBio, Inc. | -17.89 Million USD | 196.808% |
| Korro Bio, Inc. | -3.63 Million USD | 577.107% |
| Kineta, Inc. | 5.43 Million USD | -218.774% |
| BioVie Inc. | -229.37 Thousand USD | 7650.452% |
| Codexis, Inc. | 57.33 Million USD | 69.793% |
| Celularity Inc. | 6.75 Million USD | -156.388% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 14653.782% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -331.572% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -34134.038% |
| Cibus, Inc. | 1.42 Million USD | -1117.932% |
| IN8bio, Inc. | -2.5 Million USD | 792.483% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 947.309% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -2606.094% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 97.775% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 89.986% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 44507.692% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 1011.526% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 153.505% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 78.134% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 181.879% |
| Moolec Science SA | -143.3 Thousand USD | 12185.412% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 140.926% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -426.894% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 124.71% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 1016.349% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 479585.05% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -7384.734% |
| Humacyte, Inc. | -76.55 Million USD | 122.624% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 1477.804% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 2142.335% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 14180.488% |
| Notable Labs, Ltd. | 113 Thousand USD | -15226.549% |
| Immunovant, Inc. | -231 Thousand USD | 7597.403% |
| Quantum-Si incorporated | 488 Thousand USD | -3448.975% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 57830.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -830.129% |
| Acasti Pharma Inc. | -11 Thousand USD | 157545.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 8564.106% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 984.525% |
| PepGen Inc. | -1.18 Million USD | 1562.753% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 175.639% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 21071.629% |
| Immuneering Corporation | -764.13 Thousand USD | 2366.475% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 4440.602% |
| XOMA Corporation | 3.86 Million USD | -348.563% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 186.439% |
| Bionomics Limited | -434.44 Thousand USD | 4086.429% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1712.57% |
| uniQure N.V. | 2.21 Million USD | -681.896% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 118.811% |
| Forte Biosciences, Inc. | -9000.00 USD | 192533.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 2174.132% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 4063.158% |
| Altimmune, Inc. | -65.37 Million USD | 126.493% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 819.526% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 1712.57% |
| Peak Bio, Inc. | 367.76 Thousand USD | -4609.206% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 29.356% |
| Benitec Biopharma Inc. | 108 Thousand USD | -15936.111% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 22303.846% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 1539.651% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 1050.549% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 1539.651% |
| argenx SE | 1.1 Billion USD | 98.438% |
| Immunome, Inc. | -8.9 Million USD | 294.443% |
| Verona Pharma plc | -679.62 Thousand USD | 2648.321% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 9996.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 826.164% |
| CervoMed Inc. | -1.29 Million USD | 1438.794% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 462.55% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -600.89% |
| Moolec Science SA | -143.3 Thousand USD | 12185.412% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 4344.541% |
| Design Therapeutics, Inc. | -537 Thousand USD | 3325.14% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 4155.972% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -707.036% |
| Achilles Therapeutics plc | -4.73 Million USD | 466.054% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 138.024% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -40176.744% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 2206.934% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 131723.347% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 52581.818% |
| Beam Therapeutics Inc. | -59.67 Million USD | 129.024% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 87.57% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 19.615% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 5931.313% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 530.068% |
| NeurAxis, Inc. | 2.15 Million USD | -703.031% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 281.047% |
| Lumos Pharma, Inc. | 2 Million USD | -762.93% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 45.295% |
| Palisade Bio, Inc. | 246 Thousand USD | -6940.244% |
| Nutriband Inc. | 862.1 Thousand USD | -1908.92% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -23.004% |
| Neurogene Inc. | -3.26 Million USD | 630.932% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 31589.091% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 569.095% |
| Athira Pharma, Inc. | -969 Thousand USD | 1887.307% |
| HCW Biologics Inc. | -574.82 Thousand USD | 3112.922% |
| XOMA Corporation | 3.86 Million USD | -348.563% |
| Nektar Therapeutics | 53.47 Million USD | 67.615% |
| Arvinas, Inc. | 71.8 Million USD | 75.879% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 120.751% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 127.589% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 5478.571% |
| Rezolute, Inc. | -36 Thousand USD | 48208.333% |
| Clene Inc. | 533 Thousand USD | -3149.343% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 1348931.776% |
| BeyondSpring Inc. | 1.75 Million USD | -889.092% |
| Synlogic, Inc. | -1.92 Million USD | 1000.156% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 46908.108% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 373.515% |
| Peak Bio, Inc. | 367.76 Thousand USD | -4609.206% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 191.33% |
| Krystal Biotech, Inc. | 47.6 Million USD | 63.619% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 87.725% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -244.657% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 768.889% |
| MannKind Corporation | 136.19 Million USD | 87.283% |
| Ikena Oncology, Inc. | -50.49 Million USD | 134.3% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 84.084% |
| Gossamer Bio, Inc. | -4.38 Million USD | 494.96% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 6972.619% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 346480.0% |
| Legend Biotech Corporation | 140.92 Million USD | 87.711% |
| Mural Oncology plc | -2.56 Million USD | 774.679% |
| Disc Medicine, Inc. | -100 Thousand USD | 17419.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 16.551% |
| REGENXBIO Inc. | 53.02 Million USD | 67.341% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 423.299% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 9102.729% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 1099.942% |
| Vaxart, Inc. | -60.76 Million USD | 128.503% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 6690.684% |
| Cellectis S.A. | 18 Thousand USD | -96116.667% |
| Longeveron Inc. | 221 Thousand USD | -7736.652% |
| Repare Therapeutics Inc. | -80.07 Million USD | 121.63% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 98.415% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 1438.408% |
| Revolution Medicines, Inc. | -399.66 Million USD | 104.333% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 49582.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -35244.898% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.799% |
| Denali Therapeutics Inc. | -93.34 Million USD | 118.554% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 69240.485% |
| Veru Inc. | 7.56 Million USD | -128.908% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 11569.536% |
| Cingulate Inc. | -582.91 Thousand USD | 3071.087% |
| Passage Bio, Inc. | -3.72 Million USD | 565.439% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 143897.742% |
| Exicure, Inc. | -1.42 Million USD | 1317.077% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 4621.932% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -540.733% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 3478.164% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 11676.33% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 129.252% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -4329.412% |
| OmniAb, Inc. | 14.66 Million USD | -18.081% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 13.375% |
| Lipocine Inc. | -2.85 Million USD | 707.51% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 1039.718% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 403.576% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 1249.778% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 77.005% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 26744.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 79.455% |
| Ocugen, Inc. | -33.53 Million USD | 151.641% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 647.723% |
| Q32 Bio Inc. | 578 Thousand USD | -2896.367% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 6635.472% |
| Alumis Inc. Common Stock | -1.28 Million USD | 1448.832% |
| Equillium, Inc. | 35.95 Million USD | 51.835% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 1114.587% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -3359.103% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 419040.493% |
| Dominari Holdings Inc. | 2.03 Million USD | -749.387% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 9539.639% |
| vTv Therapeutics Inc. | -13.59 Million USD | 227.392% |
| Bio-Techne Corporation | 773.07 Million USD | 97.76% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 96.241% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 1581.523% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 172.223% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -48.064% |
| Nkarta, Inc. | -5.86 Million USD | 395.093% |
| BioCardia, Inc. | -7.24 Million USD | 338.916% |
| Iterum Therapeutics plc | -1.75 Million USD | 1089.657% |